Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorpor…
$4.87-9.31%
报价 2026-11-13
市值
$15.3M
EV
$40.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -70.9%
$3.06$16.74
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CTSOCytosorbents Corporation | $15.3M | -9.3% | +8.0% | 71.6% | – | – | – | |
| BDSXBiodesix, Inc. | $80.4M | +0.9% | +29.1% | 63.9% | – | – | – | |
| ECORelectroCore, Inc. | $48.4M | -0.8% | +32.9% | 87.7% | – | – | – | |
| MDAISpectral AI, Inc. | $41.8M | -3.7% | +1.1% | 41.5% | – | – | – | |
| SRTSSensus Healthcare, Inc. | $38.3M | -27.8% | -18.8% | 36.4% | – | – | – | |
| TELATELA Bio, Inc. | $37.1M | -4.6% | +7.8% | 67.2% | – | – | – | |
| TELOTelomir Pharmaceuticals, Inc. Common Stock | $36.1M | -2.0% | -99.9% | 0% | – | – | – | |
| SERSerina Therapeutics, Inc. | $20.8M | -1.4% | 0.0% | 0% | – | – | – | |
| NMTCNeuroOne Medical Technologies Corporation | $6.8M | -0.3% | +33.9% | 55.7% | – | – | – | |
| 同行中位数 | – | – | +4.5% | 48.6% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。